THE PEER-REVIEWED FORUM FOR EVIDENCE IN BENEFIT DESIGN ™ NOVEMBER/DECEMBER 2012
VOLUME 5, NUMBER 7
FOR PAYERS, PURCHASERS, POLICYMAKERS, AND OTHER HEALTHCARE STAKEHOLDERS
PERSPECTIVES
Getting Back to Reality: The Election, the Fiscal Cliff, and the ACA Joseph R. Antos, PhD
Interesting Times Ahead: Payers’ Innovation in the Era of Healthcare Reform Albert Tzeel, MD, MHSA, FACPE EDITORIAL
The Use of Medicines in the United States: A Detailed Review David B. Nash, MD, MBA ™
CLINICAL
National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications: Healthcare and Medical Professional Liability Costs Betsy J. Lahue, MPH; Bruce Pyenson, FSA, MAAA; Kosuke Iwasaki, FIAJ, MAAA, MBA; Helen E. Blumen, MD, MBA; Susan Forray, FCAS, MAAA; Jeffrey M. Rothschild, MD, MPH Stakeholder Perspective by Jaan Sidorov, MD, MHSA BUSINESS
Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging Markets Anke-Peggy Holtorf, PhD, MBA; Diana Brixner, RPh, PhD; Brandon Bellows, PharmD; Abdulkadir Keskinaslan, MD, MBA, MPH; Joseph Dye, RPh, PhD; Gary Oderda, PharmD, MPH Stakeholder Perspective by Douglas S. Burgoyne, PharmD
Hematologic Complications, Healthcare Utilization, and Costs in Commercially Insured Patients with Myelodysplastic Syndrome Receiving Supportive Care Annette Powers, PharmD, MBA; Claudio Faria, PharmD, MPH; Michael S. Broder, MD, MSHS; Eunice Chang, PhD; Dasha Cherepanov, PhD Stakeholder Perspective by Jeffrey A. Bourret, MS, RPh, FASHP Industry Trends
The Policy-Driven Health Plan: A Roadmap for Value-Based Reimbursement
©2012 Engage Healthcare Communications, LLC www.AHDBonline.com